Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.16 USD | -9.41% | -8.61% | +9.03% |
May. 09 | Stifel Adjusts Price Target on C4 Therapeutics to $14 From $13, Maintains Buy Rating | MT |
May. 08 | C4 Therapeutics Shares Decline as Q1 Revenue Misses Estimates | MT |
End-of-day quotes
Compared values
Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
---|---|---|---|---|---|---|---|---|---|---|---|
C4 THERAPEUTICS, INC. | Other Biotechnology & Medical Research | -9.41% | -8.61% | +9.03% | +82.25% | - | 424M |
- Stock Market
- Equities
- CCCC Stock
- Charts C4 Therapeutics, Inc.
- Relative Strength Chart